Related Experiment Video
Updated: Feb 25, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Proportion of daily capillary blood glucose readings required in the target range for target glycaemic control: shift
S Sivasubramaniyam1,2, S A Amiel1,3, P Choudhary1,3
1King's College London, London, UK.
Insights
People with Type 1 diabetes achieving HbA1c below 58 mmol/mol had about 60% of capillary blood glucose readings in range. This suggests a new target for diabetes management may reduce patient anxiety.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Diabetes Management
Background:
- Current guidelines for Type 1 diabetes (T1D) recommend pre- and post-meal capillary blood glucose (CBG) targets.
- Achieving optimal glycemic control is crucial for managing T1D.
Purpose of the Study:
- To evaluate the proportion of daily CBG readings within the 4-10 mmol/l range in individuals with T1D achieving different HbA1c levels.
- To explore potential new glycemic targets for T1D management.
Main Methods:
- Analysis of CBG data from 201 adults using continuous subcutaneous insulin infusion (CSII).
- Participants were categorized into three HbA1c groups: <58 mmol/mol, 58-74 mmol/mol, and ≥75 mmol/mol.
- Exclusion criteria included short CSII duration, insufficient CBG frequency, pregnancy, haemoglobinopathy, and continuous sensor use.
Main Results:
- Individuals with HbA1c <58 mmol/mol had approximately 57.3% of CBG readings within the 4-10 mmol/l target range.
- Higher HbA1c groups showed a lower percentage of readings in range (50.6% and 39.9%).
- The proportion of readings <4 mmol/l and >10 mmol/l increased with higher HbA1c levels.
Conclusions:
- Achieving approximately 60% of CBG readings within the 4-10 mmol/l range, with up to 30% exceeding 10 mmol/l, may be a viable target for T1D management.
- This potential new target could help reduce patient anxiety associated with out-of-range glucose readings.
Aim:
Most guidelines provide people with Type 1 diabetes with pre- and post-meal capillary blood glucose (CBG) targets to achieve optimal glycaemic control. We evaluated the proportion of daily CBG readings between 4 and 10 mmol/l in people achieving different HbA1c levels.
Method:
We analysed CBG data from routine pump/meter downloads from 201 adults treated with continuous subcutaneous insulin infusion (CSII) at a single hospital clinic. Exclusion criteria were CSII < 6 months, < 3 CBG/day, pregnancy, haemoglobinopathy and continuous sensor use. People were categorized into three groups based on HbA1c : < 58 mmol/mol, < 7.5% (n = 58); 58-74 mmol/mol, 7.5-8.9% (n = 107); and ≥ 75 mmol/mol, ≥ 9.0% (n = 36).
Results:
Participants had a mean age of 43 ± 13 years and mean HBA1c of 64 mmol/mol (8.0 ± 1.1%). 47% of people started CSII for raised HbA1c , 25% due to hypoglycaemia and the rest during pregnancy. Downloads contained a mean of 22 ± 6.8 days of data per participant. CBG frequency was similar between the three groups (5.6 ± 2.0, 5.6 ± 1.9 and 5.4 ± 1.2 CBG/day; P = 0.468). The proportion of CBG readings between 4 and 10 mmol/l (72-180 mg/dl) was 57.3 ± 25.4%, 50.6 ± 11.1% and 39.9 ± 16.5% (P < 0.0001); < 4 mmol was 13.8%, 8.8% and 4.4% (P < 0.0001) and > 10 mmol/l was 28.9 ± 16.5%, 40.6 ± 12.1% and 55.6 ± 17.9% (P < 0.0001) in the three groups respectively.
Conclusions:
Participants achieving HBA1c < 58 mmol/mol (< 7.5%) had ~ 60% of CBG readings in range (4-10 mmol/l), with up to 30% of readings > 10 mmol/l. This target of achieving 60% or more readings within target, and being permissive with up to 30% readings > 10 mmol/l may be a novel target for people with diabetes, and may reduce anxiety associated with readings out of range.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
Related Concept Videos
Hypoglycemia and Glucagon
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Diabetes: Symptoms, Diagnosis, and Complications
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...